The document discusses the field of vision, including its anatomy and testing methods. It notes that the field of vision is like an island surrounded by blindness, with the fovea being the summit of highest sensitivity and the blind spot being the trough of zero sensitivity. It describes kinetic and static perimetry testing methods and different types of visual field defects seen in conditions like glaucoma and neurological disorders. Global indices, reliability indices, and corrected pattern deviation maps are used to analyze perimetry results. Factors affecting testing and new techniques like FDT perimetry are also mentioned.
This document provides information about primary open-angle glaucoma (POAG):
- It defines POAG as a chronic, progressive optic neuropathy characterized by an open anterior chamber angle and elevated intraocular pressure.
- Risk factors, clinical presentation, diagnosis, differential diagnosis, evaluation, and treatment options are discussed. Treatment may involve medications, laser trabeculoplasty, or glaucoma surgery with the goal of reducing intraocular pressure to halt optic nerve damage.
- Two case studies are presented to exemplify the evaluation and treatment of patients with POAG.
This document discusses the diagnosis of pre-perimetric glaucoma. It begins by defining pre-perimetric glaucoma as optic nerve abnormalities seen on structural tests with normal visual fields. It then discusses the need for early diagnosis before functional changes occur. Various functional tests are described like standard automated perimetry, short wavelength automated perimetry, frequency doubling technology, and others. Structural tests like confocal scanning laser ophthalmoscopy, optical coherence tomography, and their principles are summarized.
This document discusses visual field testing methods and interpretation. It describes common visual field tests including confrontation, kinetic perimetry, and static automated perimetry. Normal visual fields subtend approximately 140 degrees monocularly. Automated static perimetry tests like Humphrey and Octopus are now commonly used to evaluate for conditions like glaucoma by testing the central 24 or 30 degrees. Test results are interpreted through gray scale and total deviation plots to identify localized areas of visual field loss and global indices provide an overall measure of sensitivity. Common defects seen in glaucoma include arcuate scotomas and temporal wedges. Neurological field defects can be homonymous or heteronomous depending on the lesion location.
Primary open angle glaucoma (POAG) is the most common type of glaucoma. It is characterized by a raised intraocular pressure, optic nerve damage, and visual field loss. Early signs include increased cupping of the optic nerve head and visual field defects like paracentral scotomas. Treatment aims to lower intraocular pressure through medications, laser therapy, or surgery to prevent further optic nerve damage and vision loss.
Primary angle-closure glaucoma is caused by apposition of the peripheral iris against the trabecular meshwork, obstructing aqueous outflow. It is a major cause of glaucoma blindness worldwide. Predisposing anatomical factors include a shallow anterior chamber and narrow anterior chamber angle. Precipitating factors like dim illumination or mydriatic drugs can cause a pupil block mechanism, obstructing outflow. Acute primary angle closure is a medical emergency treated with medications and laser iridotomy. Chronic primary angle closure glaucoma causes optic nerve damage and visual field loss.
This document discusses visual field testing techniques used to evaluate the peripheral visual field. It describes common manual and automated methods, including confrontation, kinetic perimetry, and static threshold testing. The document provides details on visual field devices such as the Goldmann perimeter, Humphrey Field Analyzer, and Frequency Doubling Technology perimeters. It also reviews data analysis, common defects, and the use of visual field testing to evaluate conditions like glaucoma, neurologic diseases, and side effects of medications.
The document discusses the field of vision, including its anatomy and testing methods. It notes that the field of vision is like an island surrounded by blindness, with the fovea being the summit of highest sensitivity and the blind spot being the trough of zero sensitivity. It describes kinetic and static perimetry testing methods and different types of visual field defects seen in conditions like glaucoma and neurological disorders. Global indices, reliability indices, and corrected pattern deviation maps are used to analyze perimetry results. Factors affecting testing and new techniques like FDT perimetry are also mentioned.
This document provides information about primary open-angle glaucoma (POAG):
- It defines POAG as a chronic, progressive optic neuropathy characterized by an open anterior chamber angle and elevated intraocular pressure.
- Risk factors, clinical presentation, diagnosis, differential diagnosis, evaluation, and treatment options are discussed. Treatment may involve medications, laser trabeculoplasty, or glaucoma surgery with the goal of reducing intraocular pressure to halt optic nerve damage.
- Two case studies are presented to exemplify the evaluation and treatment of patients with POAG.
This document discusses the diagnosis of pre-perimetric glaucoma. It begins by defining pre-perimetric glaucoma as optic nerve abnormalities seen on structural tests with normal visual fields. It then discusses the need for early diagnosis before functional changes occur. Various functional tests are described like standard automated perimetry, short wavelength automated perimetry, frequency doubling technology, and others. Structural tests like confocal scanning laser ophthalmoscopy, optical coherence tomography, and their principles are summarized.
This document discusses visual field testing methods and interpretation. It describes common visual field tests including confrontation, kinetic perimetry, and static automated perimetry. Normal visual fields subtend approximately 140 degrees monocularly. Automated static perimetry tests like Humphrey and Octopus are now commonly used to evaluate for conditions like glaucoma by testing the central 24 or 30 degrees. Test results are interpreted through gray scale and total deviation plots to identify localized areas of visual field loss and global indices provide an overall measure of sensitivity. Common defects seen in glaucoma include arcuate scotomas and temporal wedges. Neurological field defects can be homonymous or heteronomous depending on the lesion location.
Primary open angle glaucoma (POAG) is the most common type of glaucoma. It is characterized by a raised intraocular pressure, optic nerve damage, and visual field loss. Early signs include increased cupping of the optic nerve head and visual field defects like paracentral scotomas. Treatment aims to lower intraocular pressure through medications, laser therapy, or surgery to prevent further optic nerve damage and vision loss.
Primary angle-closure glaucoma is caused by apposition of the peripheral iris against the trabecular meshwork, obstructing aqueous outflow. It is a major cause of glaucoma blindness worldwide. Predisposing anatomical factors include a shallow anterior chamber and narrow anterior chamber angle. Precipitating factors like dim illumination or mydriatic drugs can cause a pupil block mechanism, obstructing outflow. Acute primary angle closure is a medical emergency treated with medications and laser iridotomy. Chronic primary angle closure glaucoma causes optic nerve damage and visual field loss.
This document discusses visual field testing techniques used to evaluate the peripheral visual field. It describes common manual and automated methods, including confrontation, kinetic perimetry, and static threshold testing. The document provides details on visual field devices such as the Goldmann perimeter, Humphrey Field Analyzer, and Frequency Doubling Technology perimeters. It also reviews data analysis, common defects, and the use of visual field testing to evaluate conditions like glaucoma, neurologic diseases, and side effects of medications.
This document provides an overview of characteristic visual field defects seen in glaucoma. It begins with an introduction to glaucoma and visual field testing. Common visual field defects are then described, including arcuate scotomas, paracentral scotomas, and nasal steps. The Anderson criteria for classifying a visual field defect as glaucomatous are outlined. Finally, five case studies are presented with clinical histories and interpretations of visual field tests, demonstrating different patterns of glaucomatous visual field loss corresponding to optic nerve head findings.
This document provides an overview of primary open-angle glaucoma (POAG), including its definition, risk factors, diagnosis, examination techniques, differential diagnosis, and treatment goals and methods. POAG is characterized by chronic, progressive optic nerve damage and vision loss without obvious causes. Key aspects of examination include evaluating intraocular pressure, optic disc appearance and cupping, retinal nerve fiber layer, and visual field tests. Treatment goals are to preserve vision by lowering pressure to a target level individualized for each patient based on their baseline pressure and degree of existing nerve damage.
How to interpret the visual field printout
Learn basic terms of visual field analysis
How to diagnose glaucomatous field defect
How to diagnose neurological field defect
This document provides an overview of glaucoma, including:
1. Definitions of glaucoma, classifications, examination methods, primary open angle glaucoma, primary angle closure glaucoma, and glaucoma surgeries.
2. Details on the anatomy of the eye related to aqueous humor production and drainage, as well as the causes and mechanisms of increased intraocular pressure in glaucoma.
3. Risk factors, clinical features, and management approaches for primary open angle glaucoma and primary angle closure glaucoma. Surgical management via trabeculectomy and laser trabeculoplasty is also discussed.
Primary open angle glaucoma (POAG) is the most common type of glaucoma. It is characterized by an open anterior chamber angle, optic nerve damage indicative of glaucoma, and visual field loss in the absence of a secondary cause. The major risk factor for POAG is elevated intraocular pressure (IOP) above 21 mmHg. Other risk factors include older age, African ancestry, family history of glaucoma, diabetes, and high myopia. Treatment aims to lower IOP through medications, laser therapy, or surgery to prevent further optic nerve damage and vision loss.
This document discusses primary open-angle glaucoma (POAG), including its definition, risk factors, prevalence, characteristics, symptoms, signs, progression, evaluations methods, and treatment options. POAG is the most common type of glaucoma, has no known cause but may be genetic or due to poor circulation. Treatments include pharmaceutical options like beta-blockers, prostaglandins, and surgery. The goal of treatment is to lower intraocular pressure to prevent further optic nerve damage and vision loss.
This document provides an overview of evaluating a glaucoma patient. It discusses the classification, clinical evaluation, history, clinical examination including slit lamp biomicroscopy, tonometry, gonioscopy, optic disc evaluation, visual field testing, and OCT. Classification is based on whether glaucoma is congenital or acquired, primary or secondary, open angle or angle-closure. The clinical evaluation aims to diagnose the specific form of glaucoma, determine severity, and assess disease progression. A thorough history and clinical examination are essential for appropriate glaucoma management.
Age related macular degeneration from Optometrist Point of ViewAnis Suzanna Mohamad
Age-related macular degeneration (ARMD) is a degenerative eye disease that affects the macula and can cause vision loss, with risk factors including aging, smoking, and family history. It has early and late stages, with the late stage including dry ARMD characterized by retinal pigment epithelium and photoreceptor atrophy, and wet ARMD involving abnormal blood vessel growth beneath the retina. Treatment options depend on the stage and type of ARMD, with anti-VEGF injections and photodynamic therapy used for wet ARMD to prevent further vision loss.
This document discusses visual field testing methods. It defines the visual field as the area that can be seen simultaneously without moving the eyes. Common testing methods are described, including confrontation testing, Amsler grid, tangent screen, kinetic perimetry, and static perimetry. Traquair's representation of the visual field as a hill is introduced. Physiological features like the blind spot are explained. Automated static perimetry is now the standard due to its ability to systematically and objectively measure sensitivity across the visual field. Factors affecting perimetry results are also reviewed.
Primary open angle glaucoma (POAG) is characterized by adult onset, elevated intraocular pressure (IOP) above 21 mmHg with an open iridocorneal angle, optic disc cupping, and visual field loss. Risk factors include older age, family history, higher IOP, and certain medical conditions. POAG is caused by reduced outflow of aqueous humor from the eye due to thickening of the trabecular meshwork. Diagnosis requires evidence of optic nerve damage and visual field loss in addition to elevated IOP. Treatment aims to lower IOP and prevent further vision loss through medications, laser trabeculoplasty, or surgery.
Primary open angle glaucoma (POAG) is characterized by adult onset, elevated intraocular pressure (IOP) above 21 mmHg, open iridocorneal angles, optic disc cupping, and visual field loss. It is the most common form of glaucoma, affecting about 1 in 100 people over age 40. Risk factors include increased IOP, older age, black race, family history, diabetes, low ocular perfusion pressure, myopia, and steroid use. POAG results from decreased aqueous outflow causing elevated IOP, due to thickening of the trabecular meshwork. Diagnosis requires evidence of optic nerve damage and visual field loss in addition to elevated IOP. Treatment aims
Primary open angle glaucoma (POAG) is characterized by adult onset, elevated intraocular pressure (IOP) above 21 mmHg, open iridocorneal angles, optic disc cupping, and visual field loss. It is the most common form of glaucoma, affecting about 1 in 100 people over age 40. Risk factors include increased IOP, older age, black race, family history, diabetes, low ocular perfusion pressure, myopia, and steroid use. POAG results from decreased aqueous outflow causing elevated IOP, due to thickening of the trabecular meshwork. Diagnosis requires evidence of optic nerve damage and visual field loss in addition to elevated IOP. Treatment aims
Primary open angle glaucoma (POAG) is characterized by adult onset, elevated intraocular pressure (IOP) above 21 mmHg, open iridocorneal angles, optic disc cupping, and visual field loss. The main risk factor is elevated IOP. POAG is diagnosed based on the triad of abnormalities in the optic disc, visual fields, and IOP. Treatment aims to prevent vision loss by lowering IOP through medical therapy, laser trabeculoplasty, or filtration surgery. Automated perimetry and optic nerve evaluation are important for diagnosis and monitoring progression.
Gradual vision loss is caused by many conditions that develop over weeks to years. The most common causes are age-related macular degeneration, cataracts, glaucoma, diabetic retinopathy, and refractive errors. A thorough history and eye exam can help identify the cause by examining symptoms, visual acuity, the retina, and optic nerve. Treatment depends on the specific condition but may include eye drops, laser therapy, surgery, or lifestyle changes.
Optical coherence tomography in glaucoma - Dr Shylesh DabkeShylesh Dabke
This document discusses optical coherence tomography (OCT) in evaluating glaucoma. It begins by outlining the importance of early glaucoma detection to prevent vision loss. OCT is described as the most appropriate technology for detecting glaucoma as it can assess retinal nerve fiber layer (RNFL) thickness before visual field or optic disc changes occur. RNFL thinning is an early sign of glaucoma. The document then provides details on OCT technology and analysis of RNFL thickness, optic nerve head, and macula to diagnose and monitor glaucoma. RNFL analysis, especially of the inferior quadrant, is highlighted as the most useful OCT assessment for detecting early glaucoma.
Glaucoma is a group of eye diseases that damage the optic nerve and cause vision loss. It is often associated with an abnormally high pressure inside the eye. The most common type is open-angle glaucoma, which has no symptoms until significant vision is lost. Risk factors include family history, age over 40 for African Americans and 60 for others, high eye pressure, thin corneas, and certain medical conditions. Treatment aims to lower eye pressure and prevent further vision loss through eyedrops, oral medications, laser treatment, or surgery. People with glaucoma require lifelong management to preserve their remaining sight.
Glaucoma is a progressive optic neuropathy where there is loss of retinal ganglion cells resulting in irreversible blindness if left untreated. It is often asymptomatic in the early stages and is a major cause of blindness. While elevated intraocular pressure is a strong risk factor, glaucoma can occur without elevated pressure. It is diagnosed through evaluation of the optic nerve, retinal nerve fiber layer, and visual fields. Treatment aims to lower intraocular pressure and slow disease progression to preserve vision.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
This document provides an overview of characteristic visual field defects seen in glaucoma. It begins with an introduction to glaucoma and visual field testing. Common visual field defects are then described, including arcuate scotomas, paracentral scotomas, and nasal steps. The Anderson criteria for classifying a visual field defect as glaucomatous are outlined. Finally, five case studies are presented with clinical histories and interpretations of visual field tests, demonstrating different patterns of glaucomatous visual field loss corresponding to optic nerve head findings.
This document provides an overview of primary open-angle glaucoma (POAG), including its definition, risk factors, diagnosis, examination techniques, differential diagnosis, and treatment goals and methods. POAG is characterized by chronic, progressive optic nerve damage and vision loss without obvious causes. Key aspects of examination include evaluating intraocular pressure, optic disc appearance and cupping, retinal nerve fiber layer, and visual field tests. Treatment goals are to preserve vision by lowering pressure to a target level individualized for each patient based on their baseline pressure and degree of existing nerve damage.
How to interpret the visual field printout
Learn basic terms of visual field analysis
How to diagnose glaucomatous field defect
How to diagnose neurological field defect
This document provides an overview of glaucoma, including:
1. Definitions of glaucoma, classifications, examination methods, primary open angle glaucoma, primary angle closure glaucoma, and glaucoma surgeries.
2. Details on the anatomy of the eye related to aqueous humor production and drainage, as well as the causes and mechanisms of increased intraocular pressure in glaucoma.
3. Risk factors, clinical features, and management approaches for primary open angle glaucoma and primary angle closure glaucoma. Surgical management via trabeculectomy and laser trabeculoplasty is also discussed.
Primary open angle glaucoma (POAG) is the most common type of glaucoma. It is characterized by an open anterior chamber angle, optic nerve damage indicative of glaucoma, and visual field loss in the absence of a secondary cause. The major risk factor for POAG is elevated intraocular pressure (IOP) above 21 mmHg. Other risk factors include older age, African ancestry, family history of glaucoma, diabetes, and high myopia. Treatment aims to lower IOP through medications, laser therapy, or surgery to prevent further optic nerve damage and vision loss.
This document discusses primary open-angle glaucoma (POAG), including its definition, risk factors, prevalence, characteristics, symptoms, signs, progression, evaluations methods, and treatment options. POAG is the most common type of glaucoma, has no known cause but may be genetic or due to poor circulation. Treatments include pharmaceutical options like beta-blockers, prostaglandins, and surgery. The goal of treatment is to lower intraocular pressure to prevent further optic nerve damage and vision loss.
This document provides an overview of evaluating a glaucoma patient. It discusses the classification, clinical evaluation, history, clinical examination including slit lamp biomicroscopy, tonometry, gonioscopy, optic disc evaluation, visual field testing, and OCT. Classification is based on whether glaucoma is congenital or acquired, primary or secondary, open angle or angle-closure. The clinical evaluation aims to diagnose the specific form of glaucoma, determine severity, and assess disease progression. A thorough history and clinical examination are essential for appropriate glaucoma management.
Age related macular degeneration from Optometrist Point of ViewAnis Suzanna Mohamad
Age-related macular degeneration (ARMD) is a degenerative eye disease that affects the macula and can cause vision loss, with risk factors including aging, smoking, and family history. It has early and late stages, with the late stage including dry ARMD characterized by retinal pigment epithelium and photoreceptor atrophy, and wet ARMD involving abnormal blood vessel growth beneath the retina. Treatment options depend on the stage and type of ARMD, with anti-VEGF injections and photodynamic therapy used for wet ARMD to prevent further vision loss.
This document discusses visual field testing methods. It defines the visual field as the area that can be seen simultaneously without moving the eyes. Common testing methods are described, including confrontation testing, Amsler grid, tangent screen, kinetic perimetry, and static perimetry. Traquair's representation of the visual field as a hill is introduced. Physiological features like the blind spot are explained. Automated static perimetry is now the standard due to its ability to systematically and objectively measure sensitivity across the visual field. Factors affecting perimetry results are also reviewed.
Primary open angle glaucoma (POAG) is characterized by adult onset, elevated intraocular pressure (IOP) above 21 mmHg with an open iridocorneal angle, optic disc cupping, and visual field loss. Risk factors include older age, family history, higher IOP, and certain medical conditions. POAG is caused by reduced outflow of aqueous humor from the eye due to thickening of the trabecular meshwork. Diagnosis requires evidence of optic nerve damage and visual field loss in addition to elevated IOP. Treatment aims to lower IOP and prevent further vision loss through medications, laser trabeculoplasty, or surgery.
Primary open angle glaucoma (POAG) is characterized by adult onset, elevated intraocular pressure (IOP) above 21 mmHg, open iridocorneal angles, optic disc cupping, and visual field loss. It is the most common form of glaucoma, affecting about 1 in 100 people over age 40. Risk factors include increased IOP, older age, black race, family history, diabetes, low ocular perfusion pressure, myopia, and steroid use. POAG results from decreased aqueous outflow causing elevated IOP, due to thickening of the trabecular meshwork. Diagnosis requires evidence of optic nerve damage and visual field loss in addition to elevated IOP. Treatment aims
Primary open angle glaucoma (POAG) is characterized by adult onset, elevated intraocular pressure (IOP) above 21 mmHg, open iridocorneal angles, optic disc cupping, and visual field loss. It is the most common form of glaucoma, affecting about 1 in 100 people over age 40. Risk factors include increased IOP, older age, black race, family history, diabetes, low ocular perfusion pressure, myopia, and steroid use. POAG results from decreased aqueous outflow causing elevated IOP, due to thickening of the trabecular meshwork. Diagnosis requires evidence of optic nerve damage and visual field loss in addition to elevated IOP. Treatment aims
Primary open angle glaucoma (POAG) is characterized by adult onset, elevated intraocular pressure (IOP) above 21 mmHg, open iridocorneal angles, optic disc cupping, and visual field loss. The main risk factor is elevated IOP. POAG is diagnosed based on the triad of abnormalities in the optic disc, visual fields, and IOP. Treatment aims to prevent vision loss by lowering IOP through medical therapy, laser trabeculoplasty, or filtration surgery. Automated perimetry and optic nerve evaluation are important for diagnosis and monitoring progression.
Gradual vision loss is caused by many conditions that develop over weeks to years. The most common causes are age-related macular degeneration, cataracts, glaucoma, diabetic retinopathy, and refractive errors. A thorough history and eye exam can help identify the cause by examining symptoms, visual acuity, the retina, and optic nerve. Treatment depends on the specific condition but may include eye drops, laser therapy, surgery, or lifestyle changes.
Optical coherence tomography in glaucoma - Dr Shylesh DabkeShylesh Dabke
This document discusses optical coherence tomography (OCT) in evaluating glaucoma. It begins by outlining the importance of early glaucoma detection to prevent vision loss. OCT is described as the most appropriate technology for detecting glaucoma as it can assess retinal nerve fiber layer (RNFL) thickness before visual field or optic disc changes occur. RNFL thinning is an early sign of glaucoma. The document then provides details on OCT technology and analysis of RNFL thickness, optic nerve head, and macula to diagnose and monitor glaucoma. RNFL analysis, especially of the inferior quadrant, is highlighted as the most useful OCT assessment for detecting early glaucoma.
Glaucoma is a group of eye diseases that damage the optic nerve and cause vision loss. It is often associated with an abnormally high pressure inside the eye. The most common type is open-angle glaucoma, which has no symptoms until significant vision is lost. Risk factors include family history, age over 40 for African Americans and 60 for others, high eye pressure, thin corneas, and certain medical conditions. Treatment aims to lower eye pressure and prevent further vision loss through eyedrops, oral medications, laser treatment, or surgery. People with glaucoma require lifelong management to preserve their remaining sight.
Glaucoma is a progressive optic neuropathy where there is loss of retinal ganglion cells resulting in irreversible blindness if left untreated. It is often asymptomatic in the early stages and is a major cause of blindness. While elevated intraocular pressure is a strong risk factor, glaucoma can occur without elevated pressure. It is diagnosed through evaluation of the optic nerve, retinal nerve fiber layer, and visual fields. Treatment aims to lower intraocular pressure and slow disease progression to preserve vision.
Similar to The Complete Approach To Glaucoma Evaluation (20)
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
2. DEFINITION
Glaucoma is a Chronic Optic Neuropathy with typical structural
damage in the optic disc, usually accompanied by or leading to
corresponding functional changes in the visual field
3. Causes and risk factors
• No identifiable cause for Primary glaucoma
• Secondary Glaucoma has underlying causes likeTumor, diabetes, hypothyroidism,
advanced cataract or inflammation
• R/f forGlaucoma include :
o Age
o Black race
o Diabetes
o Family history
o Eye injury or previous surgery
o Severe myopia
o Corticosteroid use, especially topical
o High blood pressure
o Genetic factors (CongenitalGlaucoma)
5. SYMPTOMS OF GLAUCOMA
CLOSED ANGLE OPEN ANGLE GLAUCOMA
Symptoms develop slowly, and a
person may not notice them until the
later stages.
They include:
• Gradual loss of peripheral vision,
usually in both eyes and
• Tunnel vision
7. ▪ Visual Complaints
▪ Ocular symptoms
▪ Medical history
▪ Current topical medications
▪ Family history
▪ Allergies to medications
▪ Systemic medications
▪ Trauma/Surgical history
History
13. Pupil Examination
▪ Glaucoma is usually an
asymmetric disease, and
demonstration of a relative
afferent pupillary defect is an
important diagnostic clue
▪ A dilated pupil may be a sign
of angle closure
14. Slit-Lamp Examination
▪ For signs of
pseudoexfoliation (PXF),
pigment dispersion, uveitis,
or trauma
▪ Pigment liberation following
dilatation – Highly suggest
PXF
15. Intraocular Pressure
Measurement
▪ Measured at every visit
▪ Desirable to obtain multiple readings throughout
the day
▪ Current gold standard --> Goldmann applanation
tonometer
▪ Corneal edema detected --> Underestimated IOP
▪ Central CornealThickness – Affect IOP reading --
>CCT Correction done
▪ 22mmhg is the cut off for Indian population
▪ Water drinking test to predict peak IOP and IOP
fluctuations
17. • POAG is a diagnosis of exclusion
• Demonstration of open angle especially
important in regions where PACD
common
• Gonioscopy is used to examine the Angle
of the anterior chamber
• Best performed with
Indentation Gonioscope and 4 mirror
type
18. • Testing conditions critical in determining
Whether angle open or closed
o Many angles open in bright room and
long slit beam (image)
• Ideal testing conditions :
•Dim room illumination
•Minimal intensity of slit lamp
illumination
Low slit beam height
No pressure on eye with gonioscope
Wait 30-45s for pupil to dilate before
deciding if angle open
19. If under these conditions, PosteriorTrabecular Meshwork
(PTM) not seen --> Pt. asked to look toward mirror to
obtain “Over the hill view” of the angle
o If >180 degree seen with such view, angle
considered open
o If not seen > Pt considered a PACS
o Next > increase illumination and slit height to
constrict pupil > Perform indentation with
gonioscope> Look for other signs of pathology in
the angle (Peripheral ant synechiae, signs of PXF,
trauma, old hemmorhage, inflammation, new
vessels)
o If other signs absent, and angles open under
conditions described above, then, in prescence of
disc of field changes > diagnosis of POAG
20. Role of Van Herrick tests and Angle
Imaging
▪ Suggested as a screening test for Angle
closure
▪ Negative test does not rule it out and positive
test still requires gonioscopy
▪ VH positive and raised IOP in combination is
highly specific
▪ Angle imaging techniques like the US
biomicroscope and ASOCT have not yet
replaced gonioscopy and therefore not
necessary for clinical use
22. • Ideal – Magnified stereoscopic
examination of disc – 60-90D lens or
contact lens with Slit Lamp
• Stereo Photographs - Current gold
standard
• Document disc findings with drawing or
imaging for future comparison
24. Increased cup to disc ratio
▪ Arbitrary statistical cut off of 0.7:1 - suspicious
– Even more suspicious if vertically oriented
▪ CDR --> Fallacious as disc size is not accounted for
▪ Size of disc estimated with a 60D lens.
– Magnification factor for 90D lens is 1.41
▪ “Normal” sized disc in India –Vertical diameter of 2.0mm
▪ Get a feel of whether the disc is Small, Medium or Large
– Ask “Is this disc physiologically allowed to have this sort of cup?”
▪ CDR difference of 0.2 is suspicious
▪ Increase in CDR over time is pathognomic for Glaucoma
▪ Also can document the Rim to disc ratio in Superior, Supertemporal, Inferotemporal,
Inferior and Nasal areas of disc
– Rim : Disc <0.1:1 considered pathology until proven otherwise
25. Changes in NRR
▪ NRR thickness follows the ISNT rule - (80%)
▪ Change in this pattern is suspicious
▪ Inferior rim thinner than temporal is highly suspicious
▪ If the rim extends to edge for one clock hour – Notch
▪ Notch is characteristic of glaucoma and produces a
functional field defect too
▪ Hemmorhage that touches NRR is specific but not
sensitive
▪ Peripapillary choroidal atrophy is a soft sign of
glaucomatous damage
▪ Significant if associated with other signs or if it
increases in size
26.
27. Nerve Fibre Layer Defect
▪ Gold standard for examination – Red free
photography
▪ Examined clinically using green filter on slit lamp or
ophthalmoscope
▪ The Inferior arcuate NFL - larger area and more clearly
seen consistent with NRR thickness
▪ Localized NFLD - Dark wedge that follows the pattern
of NFL and increases width toward periphery
– Strong predictive value for future functional changes
▪ Hemmorhage that touches NRR is specific but not
sensitive
▪ High specificity but low sensitivity.
▪ Definite sign of pathology, but can occur in other
diseases too.
28. So, the diagnosis of glaucomatous changes in the ON is usually based on
a combination of the above signs
NOTCH NFLD
Rule in
Glaucoma
Disc
Hemmorhage
Rim
Thinning
Rule in
Glaucoma
29. IMAGING TECHNIQUES
FOR EXAMINING THE
OPTIC DISC
• These instruments lack specificity and sensitivity for
routine clinical use
• Provide valuable clinical information
31. • Integral part of a full ophthalmic evaluation
•Available techniques
oTo test the full field (including confrontation, tangent screen, Goldmann perimetry and automated
perimetry),
oTo assess just the central field of vision, such as the Amsler Grid , BjerrumTangent screen
•Manual and/or automated visual field testing is subjective
•Abnormalities in the visual field - sign of damage anywhere in the visual system
o Assess whether or not a visual field defect matches the appearance of the disc and retina, or fits
with other clinical signs
• Test each eye separately -Non-congruous defects in each eye could be missed as the normal areas of
field in one eye overlap the defects in the other eye
32. • Early glaucomatous visual field defects are subtle and
easily missed
Even with modern automated and sensitive visual field
analysers, not evident until at least 30% of the retinal
ganglion cell axons that make up the optic nerve are lost
• Two major types of perimetry
o Kinetic perimetry - detection of moving targets
o Static perimetry - detection of a stationary target
• Static testing > Kinetic perimetry
• To detect glaucomatous field loss, important to test for differences in
the superior and inferior hemi-fields and hunt for defects such as a
nasal step
• Emerging technologies in visual field testing include:
Short-wavelength (blue–yellow) automated
perimetry (SWAP)
Frequency doubling technology (FDT) perimetry
Motion displacement perimetry (MDP)
33. Features of Glaucomatous Visual Field
Defects
▪ Relatively specific glaucomatous visual field defects
34. CONFRONTATION TESTING
Position
Have the patient
cover one eye
Hold a target in
the central
visual field
Move the target
from periphery
to center
Patient
indicates when
they see it
witch occluder
to cover the
opposite eye
Record Findings
35. AMSLER CHART TESTING
▪ Can be used to detect subtle central defects as well as
paracentral defects
▪ Patients hold chart at comfortable reading distance
from their uncovered eye and stare at the central spot
of the grid
• Ask them to identify and then point out any
areas where the grid is missing or distorted
• Missing areas may suggest paracentral
glaucomatous visual field loss, whereas distortion
is more common with macular disorders
36. STANDARD AUTOMATED PERIMETRY
▪ Constant size stimulus against a constant background illumination
presented in varied light intensities at particular points according to
testing strategy and minimum intensity necessary for detection of
stimulus recorded as threshold of that particular point
▪ May be performed as a threshold or suprathreshold analysis
– With suprathreshold analysis, the intensity of the stimulus target is not reduced
to the level of detection/non-detection.
– A threshold analysis is more sensitive, but takes longer and is more susceptible
to detecting artefacts
37. GOLDMANN PERIMETRY
• Enables kinetic visual field testing, and generates a permanent record of
the visual field, making it more sensitive, reproducible, and better for
detecting change overtime
• Consists of an illuminated hemispheric bowl upon which target spots of
light are shone
o Moved from non-seeing regions to seeing regions
• Kinetic testing
o Examiner moves the target where they choose throughout a test,
o Observe that the patient's eye is fixating on the fixation spot,
o Communicate with the patient and document isopters between
seeing and non-seeing regions to produce an exact drawing of visual
fields
• For static testing, the test target can be projected statically at a single
location and the brightness increased until the patient responds that the
target has been seen
38. THRESHOLD VS SUPRATHRESHOLD TESTING
SUPRATHRESHOLD
▪ Definition: Presents stimuli
well above expected thresholds
▪ Application: Quick assessment
for screening purposes
THRESHOLD
▪ Definition: Determines the
lowest intensity stimuli
detectable.
▪ Application: Quantifies and
characterizes visual field
defects
▪ More sensitive, but takes
longer and more susceptible to
detecting artefacts
39. SAP Analysis provides the following:
1. Patient data and reliability indices
2. Pictorial grey-scale plot of the visual field
3. Plot of raw data sensitivities for each test spot
4. Global indices (in dB) indicating how the height and
shape of
5. Patient's hill of vision deviates from normal.
• Mean deviation gives the average difference between the
patient's overall visual field sensitivity compared to a normal
• Pattern standard deviation gives the standard deviation of the
tested spot deviations from normal
6. Total deviation plot, with a probability map
• (indicating the likelihood for each missed point that it is
abnormal)
7. Pattern standard deviation plot, together with its
probability map
8. Analyses of change in visual field sensitivity with time
40.
41. • The key feature of a glaucomatous visual field defect is an
abnormality on the Pattern Standard Deviation plot, which
also shows on the total deviation plot
o A field defect on theTDP, in the absence of a defect on the PSDP, can
be due to glaucoma , but is more likely to be due to media opacity
o Field defect more extensive on theTDP than on the PSDP may
indicate co-morbidity (e.g. cataract and glaucoma)
42. CONCLUSION
▪ Diagnosis of established glaucoma at a stage where
treatment can prevent blindness involves the strategy of
case detection.This requires comprehensive eye
examination, including slit lamp, IOP, gonioscopy, and
detailed disc and retinal examination on all patients.
Automated Perimetry should be obtained for all suspects
43. REFERENCES
▪ Evaluation of a Glaucoma patient – RaviThomas et al
– https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038503/
▪ Visual field testing. A practical guide - Pubmed
– https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588129/